Irradiated blood products are blood components treated with ionizing radiation to prevent transfusion-associated graft-versus-host disease (TA-GvHD), a rare but often fatal complication where donor lymphocytes attack the recipient's tissues. This process effectively inactivates T-lymphocytes in the blood product, making it safe for immunocompromised patients, fetuses, and individuals receiving blood from relatives or HLA-matched donors.